PPARγ2 Pro12Ala polymorphism and TUG binding

Exploratory Score: 0.800 Price: $0.50 Diabetes Cell culture and/or biochemical assays Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting PPARγ2, Tug (Aspscr1) in Cell culture and/or biochemical assays. Primary outcome: Binding affinity between TUG product and PPARγ variants

Description

Investigation of how the PPARγ2 Pro12Ala polymorphism, which is associated with reduced diabetes risk in humans, affects the binding interaction with the TUG C-terminal product. This study provided mechanistic insight into how a protective genetic variant might enhance the metabolic benefits of the TUG cleavage pathway.

TARGET GENE
PPARγ2, Tug (Aspscr1)
MODEL SYSTEM
Cell culture and/or biochemical assays
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
PPARγ signaling
SOURCE
extracted_from_pmid_33686286
PRIMARY OUTCOME
Binding affinity between TUG product and PPARγ variants

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.800 composite

Protocol

Protein-protein interaction assays, binding studies with wild-type and variant PPARγ2

Expected Outcomes

Enhanced binding of TUG product to Pro12Ala variant compared to wild-type

Success Criteria

Measurable increase in binding affinity for the protective variant

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.